148 related articles for article (PubMed ID: 37362953)
1. Association of Opioid Use Disorder and Provision of Highly Effective Inpatient Postpartum Contraception.
Malhotra T; Sheyn D; Arora K
Open Access J Contracept; 2023; 14():95-102. PubMed ID: 37362953
[TBL] [Abstract][Full Text] [Related]
2. Changes in Rates of Inpatient Postpartum Long-Acting Reversible Contraception and Sterilization in the USA, 2012-2016.
Sheyn D; Arora KS
Matern Child Health J; 2021 Oct; 25(10):1562-1573. PubMed ID: 33970416
[TBL] [Abstract][Full Text] [Related]
3. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
[TBL] [Abstract][Full Text] [Related]
4. Provision of immediate postpartum contraception to women living with HIV in the Eastern Cape, South Africa; a cross-sectional analysis.
Adeniyi OV; Ajayi AI; Somefun OD; Lambert JS
Reprod Health; 2020 Dec; 17(1):194. PubMed ID: 33298097
[TBL] [Abstract][Full Text] [Related]
5. Increasing access to immediate postpartum contraceptive implants: a prospective clinical trial among patients with opioid use disorder.
Krans EE; Chen BA; Rothenberger SD; Bogen DL; Jones K; Turocy MJ; Klocke LC; Schwarz EB
Eur J Contracept Reprod Health Care; 2022 Dec; 27(6):478-485. PubMed ID: 36062524
[TBL] [Abstract][Full Text] [Related]
6. Update on incidence of inpatient tubal ligation and long-acting reversible contraception in the United States.
Fang NZ; Westhoff CL
Am J Obstet Gynecol; 2022 Sep; 227(3):477.e1-477.e7. PubMed ID: 35569515
[TBL] [Abstract][Full Text] [Related]
7. Documentation of prenatal contraceptive counseling and fulfillment of permanent contraception: a retrospective cohort study.
Viswanathan AV; Berg KA; Bullington BW; Miller ES; Boozer M; Serna T; Bailit JL; Arora KS
Reprod Health; 2024 Feb; 21(1):23. PubMed ID: 38355541
[TBL] [Abstract][Full Text] [Related]
8. Contraceptive initiation after delivery among women with and without opioid use disorders: A retrospective cohort study in a statewide Medicaid population, 2005-2016.
Charron E; Rennert L; Mayo RM; Eichelberger KY; Dickes L; Truong KD
Drug Alcohol Depend; 2021 Mar; 220():108533. PubMed ID: 33513446
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and acceptability of a toolkit-based process to implement patient-centered, immediate postpartum long-acting reversible contraception services.
Moniz MH; Dalton VK; Smith RD; Owens LE; Landis-Lewis Z; Peahl AF; Van Kainen B; Punch MR; Wetmore MK; Bonawitz K; Kolenic GE; Dehlendorf C; Heisler M
Am J Obstet Gynecol; 2022 Mar; 226(3):394.e1-394.e16. PubMed ID: 34655551
[TBL] [Abstract][Full Text] [Related]
10. Decomposition analysis of racial and ethnic differences in receipt of immediate postpartum, long-acting, reversible, and permanent contraception.
Rodriguez MI; Meath THA; Watson K; Daly A; McConnell KJ; Kim H
Contraception; 2024 Jun; ():110512. PubMed ID: 38852698
[TBL] [Abstract][Full Text] [Related]
11. Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder.
Krans EE; Kim JY; James AE; Kelley DK; Jarlenski M
Drug Alcohol Depend; 2018 Apr; 185():207-213. PubMed ID: 29462768
[TBL] [Abstract][Full Text] [Related]
12. Fertility intentions and the adoption of long-acting and permanent contraception (LAPM) among women: evidence from Western Kenya.
Amo-Adjei J; Mutua M; Mukiira C; Mutombo N; Athero S; Ezeh A; Izugbara C
BMC Womens Health; 2019 Feb; 19(1):26. PubMed ID: 30709344
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with use of long-acting reversible and permanent contraceptives among married women in rural Kenya: A community-based cross-sectional study in Kisii and Kilifi counties.
Orwa J; Gatimu SM; Ngugi A; Agwanda A; Temmerman M
PLoS One; 2022; 17(10):e0275575. PubMed ID: 36201509
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of immediate postpartum and post-abortion long-acting reversible contraception provision to adolescents: A systematic review.
Buckingham P; Moulton JE; Subasinghe AK; Amos N; Mazza D
Acta Obstet Gynecol Scand; 2021 Apr; 100(4):629-640. PubMed ID: 33608901
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Postpartum Uptake of Long-Acting Reversible Contraceptives Before and After Implementation of Medicaid Reimbursement Policy.
Smith M; McCool-Myers M; Kottke MJ
Matern Child Health J; 2021 Sep; 25(9):1361-1368. PubMed ID: 34109490
[TBL] [Abstract][Full Text] [Related]
16. Examining the association between short interpregnancy interval births and the type and timing of postpartum long acting reversible contraception.
Rodriguez MI; Skye M; Ramanadhan S; Schrote K; Darney BG
Contraception; 2022 Aug; 112():61-67. PubMed ID: 34971615
[TBL] [Abstract][Full Text] [Related]
17. Six- and twelve-month documented removal rates among women electing postpartum inpatient compared to delayed or interval contraceptive implant insertions after Medicaid payment reform.
Crockett AH; Pickell LB; Heberlein EC; Billings DL; Mills B
Contraception; 2017 Jan; 95(1):71-76. PubMed ID: 27400823
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
19. Postpartum contraceptive choice and fulfillment in patients with opioid use disorder.
Thomas KN; Malhotra T; Ngendahimana D; Gibson KS; Arora KS
Contraception; 2023 Dec; 128():110267. PubMed ID: 37633590
[TBL] [Abstract][Full Text] [Related]
20. Unmet demand for highly effective postpartum contraception in Texas.
Potter JE; Hopkins K; Aiken AR; Hubert C; Stevenson AJ; White K; Grossman D
Contraception; 2014 Nov; 90(5):488-95. PubMed ID: 25129329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]